Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.1%

7 terminated out of 58 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

16%

9 trials in Phase 3/4

Results Transparency

21%

6 of 28 completed with results

Key Signals

6 with results80% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (25)
P 1 (8)
P 2 (7)
P 3 (3)
P 4 (6)

Trial Status

Completed28
Unknown13
Recruiting7
Terminated7
Withdrawn2
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT06326203Phase 1Not Yet Recruiting

Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia

NCT03725111Not ApplicableCompletedPrimary

Haemodynamics Variations of Transcutaneous Oxygen in Patient With Areterio-venous Leg Ulcers Under Venous Compression

NCT07350811Completed

Retrospective, Observationnal Study to Investigate Procedural Analgesia Delivered to Patients With Lacerations, Abrasions, Burns and Leg Ulcers.

NCT06007703Completed

Evaluation of the Efficacy of Multilayer Compression & UrgoStart Plus

NCT01673412Not ApplicableCompletedPrimary

Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers

NCT04980898Not ApplicableTerminatedPrimary

Electrostimulation System WoundEL for Leg Ulcers Healing (

NCT07089602Phase 4Recruiting

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

NCT02280733Recruiting

A Real-World Registry of Chronic Wounds and Ulcers

NCT06153589Not ApplicableRecruiting

Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care

NCT06255288Not ApplicableCompletedPrimary

Time to Heal (Wound, Healing, Dialogue, Nutrition)

NCT06826339Phase 4Recruiting

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

NCT06560502Not ApplicableRecruiting

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

NCT06674980Not ApplicableRecruiting

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

NCT06036485Not ApplicableWithdrawnPrimary

Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures

NCT05303805Phase 4RecruitingPrimary

Topical Sevoflurane for Treatment of Chronic Leg Ulcers

NCT05057793Not ApplicableTerminated

Efficacy Study for Geko Device in VLU Patients (Canada)

NCT05148390CompletedPrimary

Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical Practice

NCT05619237Not ApplicableCompleted

Pivotal Study of an Antimicrobial Wound Dressing to Treat Chronic Wounds

NCT06084546Not ApplicableUnknownPrimary

Geko™ KM40C Hydrogel Skin Adhesion Trial (XW-3)

NCT03396731Not ApplicableCompleted

Efficacy Study for Geko Device in VLU Patients

Scroll to load more

Research Network

Activity Timeline